Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($1.89), $1.71 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.